GLP-1 drugs: what KanCare paid

Q: Does a paid prescription mean KanCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

KanCare shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read KanCare's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What KanCare’s payment record shows

In 2026Q1, the product KanCare paid for most often was Zepbound®, at 4,449 prescriptions¹ of the 8,359 to 8,467^1,7,13,19,43 across all 8 products, or 53 percent of the published count.

KanCare itself reimbursed at least $9,008,282 for these products in the quarter, about $1,079 per prescription. Pharmacies were paid $9,209,558 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,289.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what KanCare finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, KanCare. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What KanCare paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what KanCare paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 4,449¹	53%	$4,694,385	$4,736,553	$1,055
tirzepatideMounjaro®	Managed care	1,312⁷	16%	$1,342,736	$1,419,393	$1,023
semaglutideWegovy®	Managed care	at least 1,507¹³	18%	$1,942,840	$1,984,477	$1,289
semaglutideOzempic®	Managed care	1,039¹⁹	12%	$1,006,397	$1,044,906	$969
semaglutideRybelsus®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Managed care	at least 40⁴³	<1%	$21,923	$24,229	$548

Every published claim in this record came through managed care, meaning a plan the program contracts with paid the pharmacy. This record shows no fee-for-service claims for these products. That is a fact about how the file reports, and it points at who to ask: the plan named on your card.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 1,039 against 166. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 25.4 to 25.7 prescriptions per thousand people enrolled in KanCare, on an average of 328,921 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 7 of the 168 product-quarters it holds a row for here, which is 4 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether KanCare pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what KanCare paid for each product, quarter by quarter

Prescriptions KanCare paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld2 of 2 product codes withheld	at least 222 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$194,509 paid	at least 1,773 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$1,725,298 paid	at least 3,040 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$2,998,062 paid	at least 4,511 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$4,470,746 paid	at least 5,589 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$5,693,114 paid	at least 6,952 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$7,125,029 paid	at least 7,127 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$7,419,522 paid	at least 7,291 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$7,639,142 paid	at least 4,449 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$4,694,385 paid
tirzepatideMounjaro®range 314 to 2,167, down 855 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 11 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$9,598 paid	at least 119 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$82,354 paid	314 paid prescriptions in the quarter (2023Q1)¹⁰Count$262,614 paid	544 paid prescriptions in the quarter (2023Q2)¹⁰Count$474,839 paid	724 paid prescriptions in the quarter (2023Q3)¹⁰Count$641,988 paid	at least 830 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$810,005 paid	1,017 paid prescriptions in the quarter (2024Q1)⁹Count$866,542 paid	1,114 paid prescriptions in the quarter (2024Q2)⁹Count$999,547 paid	1,142 paid prescriptions in the quarter (2024Q3)⁹Count$1,064,271 paid	at least 1,427 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$1,347,704 paid	at least 1,579 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$1,516,204 paid	1,798 paid prescriptions in the quarter (2025Q2)⁸Count$1,741,261 paid	1,911 paid prescriptions in the quarter (2025Q3)⁸Count$1,887,210 paid	2,167 paid prescriptions in the quarter (2025Q4)⁸Count$2,157,945 paid	1,312 paid prescriptions in the quarter (2026Q1)⁷Count$1,342,736 paid
semaglutideWegovy®range 318 to 2,891	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	at least 148 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld¹⁸At least$110,013 paid	318 paid prescriptions in the quarter (2022Q1)¹⁷Count$391,093 paid	368 paid prescriptions in the quarter (2022Q2)¹⁷Count$473,069 paid	at least 348 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$433,021 paid	at least 360 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$457,892 paid	1,645 paid prescriptions in the quarter (2023Q1)¹⁶Count$2,055,751 paid	2,891 paid prescriptions in the quarter (2023Q2)¹⁶Count$3,523,419 paid	2,354 paid prescriptions in the quarter (2023Q3)¹⁶Count$2,881,869 paid	1,621 paid prescriptions in the quarter (2023Q4)¹⁶Count$2,210,733 paid	1,471 paid prescriptions in the quarter (2024Q1)¹⁵Count$1,557,073 paid	1,168 paid prescriptions in the quarter (2024Q2)¹⁵Count$1,385,945 paid	895 paid prescriptions in the quarter (2024Q3)¹⁵Count$1,020,491 paid	811 paid prescriptions in the quarter (2024Q4)¹⁵Count$953,098 paid	935 paid prescriptions in the quarter (2025Q1)¹⁴Count$1,133,775 paid	1,109 paid prescriptions in the quarter (2025Q2)¹⁴Count$1,363,845 paid	1,701 paid prescriptions in the quarter (2025Q3)¹⁴Count$2,154,359 paid	2,277 paid prescriptions in the quarter (2025Q4)¹⁴Count$2,917,853 paid	at least 1,507 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$1,942,840 paid
semaglutideOzempic®range 163 to 1,850	166 paid prescriptions in the quarter (2021Q1)²⁴Count$113,289 paid	163 paid prescriptions in the quarter (2021Q2)²⁴Count$105,577 paid	173 paid prescriptions in the quarter (2021Q3)²⁴Count$110,132 paid	at least 206 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$92,260 paid	214 paid prescriptions in the quarter (2022Q1)²³Count$140,172 paid	320 paid prescriptions in the quarter (2022Q2)²³Count$193,285 paid	361 paid prescriptions in the quarter (2022Q3)²³Count$224,326 paid	337 paid prescriptions in the quarter (2022Q4)²³Count$215,564 paid	485 paid prescriptions in the quarter (2023Q1)²²Count$274,985 paid	461 paid prescriptions in the quarter (2023Q2)²²Count$291,473 paid	at least 674 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$502,505 paid	915 paid prescriptions in the quarter (2023Q4)²²Count$791,843 paid	1,328 paid prescriptions in the quarter (2024Q1)²¹Count$1,004,125 paid	at least 1,827 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$1,489,642 paid	at least 1,843 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$1,503,518 paid	at least 1,928 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$1,627,276 paid	1,784 paid prescriptions in the quarter (2025Q1)²⁰Count$1,577,724 paid	1,850 paid prescriptions in the quarter (2025Q2)²⁰Count$1,689,406 paid	1,753 paid prescriptions in the quarter (2025Q3)²⁰Count$1,615,563 paid	at least 1,709 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$1,611,195 paid	1,039 paid prescriptions in the quarter (2026Q1)¹⁹Count$1,006,397 paid
semaglutideRybelsus®range 61 to 74	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	at least 19 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$10,266 paid	at least 17 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$6,990 paid	at least 19 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$7,975 paid	at least 18 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$8,357 paid	at least 32 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$14,131 paid	at least 54 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$33,587 paid	at least 68 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$47,963 paid	at least 48 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$34,945 paid	at least 33 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$25,005 paid	at least 25 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$22,237 paid	74 paid prescriptions in the quarter (2024Q1)²⁷Count$47,832 paid	68 paid prescriptions in the quarter (2024Q2)²⁷Count$48,800 paid	72 paid prescriptions in the quarter (2024Q3)²⁷Count$53,613 paid	61 paid prescriptions in the quarter (2024Q4)²⁷Count$48,452 paid	at least 48 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$42,575 paid	at least 33 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$31,176 paid	at least 36 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$35,133 paid	at least 36 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$32,979 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable²⁵Withheld3 of 3 product codes withheld
liraglutideSaxenda®range 34 to 1,206	421 paid prescriptions in the quarter (2021Q1)³⁶Count$510,741 paid	538 paid prescriptions in the quarter (2021Q2)³⁶Count$648,423 paid	651 paid prescriptions in the quarter (2021Q3)³⁶Count$777,032 paid	630 paid prescriptions in the quarter (2021Q4)³⁶Count$544,297 paid	620 paid prescriptions in the quarter (2022Q1)³⁵Count$234,962 paid	804 paid prescriptions in the quarter (2022Q2)³⁵Count$963,329 paid	964 paid prescriptions in the quarter (2022Q3)³⁵Count$1,116,052 paid	1,206 paid prescriptions in the quarter (2022Q4)³⁵Count$1,357,153 paid	1,156 paid prescriptions in the quarter (2023Q1)³⁴Count$1,300,971 paid	983 paid prescriptions in the quarter (2023Q2)³⁴Count$1,100,047 paid	674 paid prescriptions in the quarter (2023Q3)³⁴Count$716,596 paid	267 paid prescriptions in the quarter (2023Q4)³⁴Count$296,858 paid	117 paid prescriptions in the quarter (2024Q1)³³Count$82,809 paid	98 paid prescriptions in the quarter (2024Q2)³³Count$109,307 paid	79 paid prescriptions in the quarter (2024Q3)³³Count$80,643 paid	71 paid prescriptions in the quarter (2024Q4)³³Count$73,338 paid	62 paid prescriptions in the quarter (2025Q1)³²Count$66,943 paid	50 paid prescriptions in the quarter (2025Q2)³²Count$62,001 paid	34 paid prescriptions in the quarter (2025Q3)³²Count$42,861 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 87 to 1,078	1,078 paid prescriptions in the quarter (2021Q1)⁴²Count$884,115 paid	1,043 paid prescriptions in the quarter (2021Q2)⁴²Count$872,946 paid	893 paid prescriptions in the quarter (2021Q3)⁴²Count$750,100 paid	803 paid prescriptions in the quarter (2021Q4)⁴²Count$470,102 paid	713 paid prescriptions in the quarter (2022Q1)⁴¹Count$617,231 paid	727 paid prescriptions in the quarter (2022Q2)⁴¹Count$640,723 paid	649 paid prescriptions in the quarter (2022Q3)⁴¹Count$554,777 paid	551 paid prescriptions in the quarter (2022Q4)⁴¹Count$477,675 paid	528 paid prescriptions in the quarter (2023Q1)⁴⁰Count$463,574 paid	536 paid prescriptions in the quarter (2023Q2)⁴⁰Count$473,569 paid	463 paid prescriptions in the quarter (2023Q3)⁴⁰Count$403,896 paid	392 paid prescriptions in the quarter (2023Q4)⁴⁰Count$387,783 paid	369 paid prescriptions in the quarter (2024Q1)³⁹Count$210,720 paid	268 paid prescriptions in the quarter (2024Q2)³⁹Count$156,178 paid	87 paid prescriptions in the quarter (2024Q3)³⁹Count$55,610 paid	at least 25 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$18,344 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³⁷No row
liraglutideliraglutide (generic)range 88 to 113	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	88 paid prescriptions in the quarter (2024Q3)⁴⁵Count$54,469 paid	113 paid prescriptions in the quarter (2024Q4)⁴⁵Count$63,641 paid	105 paid prescriptions in the quarter (2025Q1)⁴⁴Count$56,120 paid	at least 95 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$46,489 paid	at least 70 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$30,337 paid	at least 98 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$52,624 paid	at least 40 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$21,923 paid

What this page cannot tell you

Whether KanCare covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Kansas in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, KS
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1008"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, KS
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1773"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, KS
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1302"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, KS
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, KS
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like ZEPBOUND%, state KS, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, KS
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like ZEPBOUND%, state KS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, KS
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "311"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, KS
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "500"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, KS
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "382"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, KS
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "235"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, KS
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, KS
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like MOUNJARO%, state KS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, KS
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "353"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, KS
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "552"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, KS
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "814"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, KS
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "973"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, KS
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "240"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, KS
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, KS
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "391"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, KS
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "724"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, KS
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "905"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, KS
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "478"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, KS
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "170"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, KS
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "114"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, KS
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, KS
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, KS
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, KS
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "35"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, KS
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, KS
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "19"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, KS
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like SAXENDA%, state KS, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, KS
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, KS
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "117"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, KS
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1156"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, KS
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1206"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, KS
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "651"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, KS
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like VICTOZA%, state KS, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, KS
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, KS
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "224"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, KS
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "341"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, KS
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, KS
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "672"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, KS
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state KS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "KS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, KS
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state KS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "45"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, KS
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state KS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, KS
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state KS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like LIRAGLUTID%, state KS, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, KS
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state KS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like LIRAGLUTID%, state KS, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, KS
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state KS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "KS", "product_name": "product_name like LIRAGLUTID%, state KS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 40 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 8 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean KanCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.